Conflicts of interest for junior faculty members were evaluated at top cancer centers by Suneel D. Kamath, MD, et al. to determine how financial conflicts of interest correlated with measures of academic career productivity.
Andrew A. Davis, MD
Advertisement
Articles by Andrew A. Davis, MD
Experts review the current landscape and potential use of neoadjuvant chemotherapy with additional novel agents for patients with localized TNBC.
Advertisement
Latest Updated Articles
Novel Neoadjuvant Treatment Strategies for Triple-Negative Breast CancerPublished: May 13th 2020 | Updated:
Association of Financial Conflicts of Interest With Academic Productivity Among Junior Faculty in Hematology and OncologyPublished: February 18th 2022 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
Pembrolizumab Combo Significantly Improves PFS/OS in Recurrent PROC
2
Tarlatamab Plus Chemo/IO Regimens Are Safe, Elicit Responses in ES-SCLC
3
ASCENT-03 Trial Supports Standard Use of Sacituzumab Govitecan in mTNBC
4
Regorafenib/Nivolumab Exhibits Nonsuperior Survival in Gastric Cancer
5
